Ventilator-Associated Pneumonia
Etiologies of Nonresolving Pneumonia
Managing Nonresolving Pneumonia
Antimicrobials Used to Treat Pneumonia
Pulmonary Host Defenses
Individualized short antibiotic course non-inferior to usual course in VAP
An individualized short antibiotic course was non-inferior to usual care in those with ventilator-associated pneumonia when assessing mortality and pneumonia recurrence at day 60, according to study results.
Ceftriaxone lessens early ventilator-associated pneumonia in patients with brain injury
One dose of ceftriaxone lowered the risk for ventilator-associated pneumonia within the first week of mechanical ventilation among patients with acute brain injury, according to results published in The Lancet Respiratory Medicine.
Inhaled amikacin lowers incidence of ventilator-associated pneumonia
Fewer critically ill adults who received inhaled amikacin vs. placebo for 3 days developed ventilator-associated pneumonia by day 28, according to results published in The New England Journal of Medicine.
Prone positioning does not shorten time to successful ECMO weaning in ARDS
Time to successful weaning off of extracorporeal membrane oxygenation was similar for prone and supine positioning among patients with severe acute respiratory distress syndrome, according to results published in JAMA.
Aztreonam-avibactam effective against MDR pathogens in REVISIT trial
BOSTON — Aztreonam-avibactam was shown to be effective in the treatment of hospitalized adults who were critically ill with multidrug-resistant, gram-negative bacterial infections, according to the results of the phase 3 REVISIT trial.
Q&A: Breath test detects ventilator-associated pneumonia in minutes
A new breath test took less than 10 minutes to screen for ventilator-associated pneumonia, or VAP, in ICU patients, according to a study published in Talanta.